MBP and myeloid sarcoma: To elucidate the effect of MBP peptides comprising the liposomal peptide therapeutic on pDCs, expression of surface activation markers and cytokine production was analyzed in MS and HD pDCs, incubated with GH17, GK16, and QR24.